Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Chen Xiaomei, Jianyu Weng, MD, Peilong Lai, Xin Huang, Wang Yulian, Suxia Geng, Liyan Guo, Tian Huang, Lingji Zeng, Xin Du, MD PhD

Blood (2018) 132 (Supplement 1): 5680.

https://doi.org/10.1182/blood-2018-99-114556

Published: 2018

Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Blood (2018) 132 (Supplement 1): 5637.

https://doi.org/10.1182/blood-2018-99-116844

Published: 2018

Journal Articles

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Jun Ma, MD, Ting Liu, MD, Jie Jin, MD PhD, Jianda Hu, MD PhD, Qifa Liu, MD, Jianxiang Wang, MD, Zhixiang Shen, MD, Xin Du, MD PhD, Bin Jiang, MD, Xianhua Meng, PhD

Blood (2016) 128 (22): 5198.

https://doi.org/10.1182/blood.V128.22.5198.5198

Published: 2016

Journal Articles

Trend and Geographic Variations in the Incidence of Waldenstrom’s Macroglobulinemia in the United States over 17 Years from 1988 to 2004.

Michael Wang, MD, Yuhong Zhou, MD, Haijun Wang, MD, Qing Yi, MD, PhD, Yanxia Zhang, MD, Raymond Alexanian, MD, Larry Kwak, MD, Ph.D., Xin Du, MD, PhD

Blood (2007) 110 (11): 5174.

https://doi.org/10.1182/blood.V110.11.5174.5174

Published: 2007

Journal Articles

Retrospective Comparison of Lymphocyte Subsets in the Different Stage of Patients with Chronic Graft-Versus-Host Disease after HSCT for Possibility of Early Diagnosis.

Haizhou Xing, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Zesheng Lu, MD, Jianjun Zhang, MD, Maohua Zhou, MD

Blood (2007) 110 (11): 4967.

https://doi.org/10.1182/blood.V110.11.4967.4967

Published: 2007

Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2007) 110 (11): 4968.

https://doi.org/10.1182/blood.V110.11.4968.4968

Published: 2007

Journal Articles

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Chengwei Luo, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Rong Guo, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4969.

https://doi.org/10.1182/blood.V110.11.4969.4969

Published: 2007

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

Journal Articles

Modified Topotecan Combination with Cyclophosphamide and Ara-C (CAT) for Patients with Refractory/Relapsed Leukemia.

Sui-jing Wu, MD, Xin Du, MD, PhD, Wei Lin, MD, Zi-lun Huang, MD, Xiao-li Zhou, MD, Jian-yu Weng, MD, Li-ye Zhong, MD, Ze-sheng Lu, MD

Blood (2007) 110 (11): 4357.

https://doi.org/10.1182/blood.V110.11.4357.4357

Published: 2007

Journal Articles

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Suijing Wu, MD, Xin Du, MD, PhD, Wei Lin, MD, Jianyu Weng, MD, Jianjun Zhang, MD, Maohua Zhou, MD, Zhixin Huang, MD, Jianhua Su, MD, Zilun Huang, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4358.

https://doi.org/10.1182/blood.V110.11.4358.4358

Published: 2007

Journal Articles

Trend and Geographic Variations in the Incidence of Mantle Cell Lymphoma in the United States over 30 Years from 1975 to 2004.

Yuhong Zhou, MD, Haijun Wang, MD, Xin Du, MD, PhD, Qing Yi, MD, PhD, Yanxia Zhang, MD, Jorge Romaguera, MD, Michael Wang, MD

Blood (2007) 110 (11): 4414.

https://doi.org/10.1182/blood.V110.11.4414.4414

Published: 2007

Journal Articles

Analysis T Cell Receptor Excision Circles (TRECs) in Patients with Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Jianyu Weng, MD, Zesheng Lu, MD, Rong Guo, MD, Shaohua Chen, MD, Lijian Yang, MD, Suxia Geng, MD, Zhilun Huang, MD

Blood (2006) 108 (11): 5272.

https://doi.org/10.1182/blood.V108.11.5272.5272

Published: 2006

Journal Articles

Monitoring JAK3 mRNA Levels in Patients with GVHD after Allogeneic Hematopoietic Stem Cell Transplantation by Real-Time Quantitative PCR.

Qihui Li, Xin Du, MD, PhD, Suxia Geng, MD, Jianyu Weng, MD, Rong Guo, MD, Zesheng Lu, MD, Haizhou Xing

Blood (2006) 108 (11): 5273.

https://doi.org/10.1182/blood.V108.11.5273.5273

Published: 2006

NARROW

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Trend and Geographic Variations in the Incidence of Waldenstrom’s Macroglobulinemia in the United States over 17 Years from 1988 to 2004.

Retrospective Comparison of Lymphocyte Subsets in the Different Stage of Patients with Chronic Graft-Versus-Host Disease after HSCT for Possibility of Early Diagnosis.

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Modified Topotecan Combination with Cyclophosphamide and Ara-C (CAT) for Patients with Refractory/Relapsed Leukemia.

Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.

Trend and Geographic Variations in the Incidence of Mantle Cell Lymphoma in the United States over 30 Years from 1975 to 2004.

Analysis T Cell Receptor Excision Circles (TRECs) in Patients with Graft-Versus-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation.

Monitoring JAK3 mRNA Levels in Patients with GVHD after Allogeneic Hematopoietic Stem Cell Transplantation by Real-Time Quantitative PCR.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only